CITATION

Keogh, James. Schaum's Outline of Pharmacology. US: McGraw-Hill, 2010.

Schaum's Outline of Pharmacology

Authors:

Published:  January 2010

eISBN: 9780071623636 0071623639 | ISBN: 9780071623629
  • Contents
  • Chapter 1. What Is Pharmacology?
  • 1.1 Definition
  • 1.2 The Roots of Pharmacology
  • 1.3 The Sources of Pharmaceuticals
  • 1.4 Herbals
  • 1.5 The United States Pharmacopeia National Formulary
  • 1.6 The 1938 Food, Drug, and Cosmetic Act
  • 1.7 The 1952 Durham-Humphrey Amendment to the Food, Drug, and Cosmetic Act
  • 1.8 The 1962 Kefauver-Harris Amendment to the Food, Drug, and Cosmetic Act
  • 1.9 The 1970 Comprehensive Drug Abuse Prevention and Control Act
  • 1.10 Medication Names
  • 1.11 Medication Effects
  • 1.12 Medication Safety
  • 1.13 The Human Trial
  • 1.14 Pregnancy Categories
  • Chapter 2. Medication Actions and Interactions
  • 2.1 Medication Actions
  • 2.2 Multiple Medication Actions
  • 2.3 Strength of Medication Action
  • 2.4 Medication Activity
  • 2.5 The Pharmaceutic Phase
  • 2.6 Pharmacokinetics
  • 2.7 Medication Absorption
  • 2.8 Absorption Rate
  • 2.9 Bioavailability
  • 2.10 Medication Concentration
  • 2.11 Distribution
  • 2.12 Medication Accumulation
  • 2.13 Elimination
  • 2.14 The First Pass Effect
  • 2.15 Pharmacodynamics
  • 2.16 Medication Time Response
  • 2.17 Receptor Theory
  • 2.18 Agonist and Antagonist
  • 2.19 Categories of Medication Action
  • 2.20 Therapeutic Index and Therapeutic Range
  • 2.21 Peak and Trough Levels
  • 2.22 Side Effects
  • 2.23 Allergic Reactions
  • Chapter 3. Pharmacology and the Nursing Process
  • 3.1 The Nursing Process
  • 3.2 Assessment Related to Drugs
  • 3.3 Patient Information
  • 3.4 Nursing Diagnosis
  • 3.5 Planning
  • 3.6 Teaching the Patient about Medication
  • 3.7 Prompt for Feedback
  • 3.8 Medication Plan
  • 3.9 Impact of Cultural Influences in Medication Administration
  • 3.10 Culture-Based Communication
  • 3.11 Genetic Considerations
  • 3.12 Maternity
  • 3.13 Pediatrics
  • 3.14 Elderly Patients
  • 3.15 Assessing Elderly People
  • Chapter 4. Substance Abuse
  • 4.1 Medication Misuse and Abuse
  • 4.2 Behavioral Patterns of Addiction
  • 4.3 Substance Abuse and Healthcare Professionals
  • 4.4 Detecting Substance Abuse
  • 4.5 Delayed Detection with Healthcare Professionals
  • 4.6 Testing for Substance Abuse
  • 4.7 Why Substances Are Abused
  • 4.8 Characteristics of Frequently Abused Medications
  • 4.9 Dependence versus Tolerance
  • 4.10 Pathophysiologic Changes
  • 4.11 Commonly Abused Substances
  • 4.12 Assessment for Substance Abuse
  • Chapter 5. Principles of Medication Administration
  • 5.1 The Process of Medication Administration
  • 5.2 Assessment Required for Specific Medications
  • 5.3 Administering Medication
  • 5.4 Preparing the Medication
  • 5.5 Administering the Medication
  • 5.6 Useful Tips When Administering Medication
  • 5.7 Avoiding Medication Errors
  • 5.8 Proper Disposal of Medication
  • 5.9 Administering Medication at Home
  • 5.10 Controlling Narcotics
  • Chapter 6. Route of Administration
  • 6.1 Medication and Routes
  • 6.2 Oral Route
  • 6.3 Sublingual and Buccal Medication Routes
  • 6.4 Transdermal Route
  • 6.5 Topical Route
  • 6.6 Instillation Route
  • 6.7 Inhalation Route
  • 6.8 Nasogastric and Gastrostomy Tubes Route
  • 6.9 Suppositories Route
  • 6.10 Parenteral Route
  • 6.11 Intradermal Parenteral Route
  • 6.12 Subcutaneous Parenteral Route
  • 6.13 Intramuscular Parenteral Route
  • 6.14 Z-Track Injection Technique
  • 6.15 Minimize Pain Parenteral Route
  • 6.16 Intravenous Parenteral Route
  • Chapter 7. Dose Calculations
  • 7.1 Medication Measurements
  • 7.2 Converting Metric Units
  • 7.3 Converting Metric Units to Apothecaries' System Units
  • 7.4 Calculating the Desired Dose
  • 7.5 The Formula Method
  • 7.6 Ratio-Proportion
  • 7.7 Calculating the IV Flow Rate
  • 7.8 Pediatric Dose Calculation Formula
  • 7.9 Heparin Dose Calculation Formula
  • 7.10 Dopamine Dose Calculation Formula
  • Chapter 8. Herbal Therapy
  • 8.1 Understanding Herbal Therapy
  • 8.2 Lack of Uniform Information
  • 8.3 Herbal Therapies and Patients
  • 8.4 Forms of Herbal Therapies
  • 8.5 Hazards of Herbal Therapeutics
  • 8.6 Herbal Therapy and the Nursing Process
  • 8.7 Avoiding Common Herbal Therapy Errors
  • 8.8 Common Herbal Therapies
  • Chapter 9. Vitamins and Minerals
  • 9.1 Vitamins
  • 9.2 A Well-Balanced Diet
  • 9.3 Recommended Dietary Allowance
  • 9.4 Fat-Soluble Vitamins
  • 9.5 Water-Soluble Vitamins
  • 9.6 Vitamins and Assessment
  • 9.7 Vitamins and Vitamin Supplements
  • 9.8 Vitamins and Teaching
  • 9.9 Minerals
  • Chapter 10. Fluid and Electrolyte Therapy
  • 10.1 Body Fluids
  • 10.2 Electrolytes
  • 10.3 Fluid Movement
  • 10.4 Fluid Concentration
  • 10.5 Intravenous Fluids
  • 10.6 Classification of Intravenous Solutions
  • 10.7 Blood and Blood Products
  • 10.8 Fluid Replacement
  • 10.9 Replacing Fluid
  • 10.10 Risk of Replacing Fluid
  • 10.11 Potassium
  • 10.12 Hyperkalemia
  • 10.13 Responding to Hyperkalemia
  • 10.14 Hypokalemia
  • 10.15 Responding to Hypokalemia
  • 10.16 Sodium
  • 10.17 Hypernatremia
  • 10.18 Responding to Hypernatremia
  • 10.19 Hyponatremia
  • 10.20 Responding to Hyponatremia
  • 10.21 Calcium
  • 10.22 Hypercalcemia
  • 10.23 Responding to Hypercalcemia
  • 10.24 Hypocalcemia
  • 10.25 Responding to Hypocalcemia
  • 10.26 Magnesium
  • 10.27 Hypermagnesemia
  • 10.28 Responding to Hypermagnesemia
  • 10.29 Hypomagnesemia
  • 10.30 Responding to Hypomagnesemia
  • 10.31 Phosphorus
  • 10.32 Hyperphosphatemia
  • 10.33 Responding to Hyperphosphatemia
  • 10.34 Hypophosphatemia
  • 10.35 Responding to Hypophosphatemia
  • Chapter 11. Nutritional Support Therapies
  • 11.1 Nutrition
  • 11.2 Malnutrition
  • 11.3 Nutritional Support Therapy
  • 11.4 Enteral Nutrition Support Therapy
  • 11.5 Group of Enteral Feeding Preparations
  • 11.6 Enteral Feeding Preparations
  • 11.7 Ways to Administer Enteral Feeding Preparations
  • 11.8 Complications of Enteral Feeding
  • 11.9 Calculating Enteral Feedings
  • 11.10 Administering Enteral Feeding Preparations
  • 11.11 Parenteral Nutrition Support Therapy
  • 11.12 Risk of Parenteral Nutrition Support Therapy
  • 11.13 Administering Parenteral Nutrition Support Therapy
  • Chapter 12. Inflammation and Anti-Inflammatory Medication
  • 12.1 The Inflammation Process
  • 12.2 Signs of Inflammation
  • 12.3 Phases of Inflammation
  • 12.4 Anti-Inflammatory Medication
  • 12.5 Categories of Anti-inflammatory Medication
  • 12.6 Corticosteroids
  • 12.7 Nonsteroidal Anti-inflammatory Drugs
  • 12.8 Arthritis Medication
  • 12.9 Gout Medication
  • Chapter 13. Infection and Antimicrobials
  • 13.1 Microorganisms
  • 13.2 Natural Defense
  • 13.3 Medication for Symptoms
  • 13.4 Antimicrobials
  • 13.5 How Antimicrobials Work
  • 13.6 Side Effects of Antimicrobials
  • 13.7 Super Infections
  • 13.8 Preventing Antibiotic-Resistant Bacteria
  • 13.9 Administering Antimicrobial Medication
  • 13.10 Patient Information for Antimicrobial Medication
  • 13.11 Penicillin
  • 13.12 Classification of Penicillin
  • 13.13 Precautions When Administering Penicillin
  • 13.14 Penicillin and Drug–Drug Interactions
  • 13.15 Penicillin and Patient Education
  • 13.16 Cephalosporin
  • 13.17 Before Administering Cephalosporin
  • 13.18 Generations of Cephalosporins
  • 13.19 Cephalosporin and Drug–Drug Interactions
  • 13.20 Cephalosporin and Patient Education
  • 13.21 Macrolide Antibiotics
  • 13.22 Administering Macrolide Antibiotics
  • 13.23 Macrolides and Drug–Drug Interactions
  • 13.24 Macrolides and Patient Education
  • 13.25 Lincomycins
  • 13.26 Administering Lincomycin Antibiotics
  • 13.27 Lincomycins and Drug–Drug Interactions
  • 13.28 Lincomycins and Patient Education
  • 13.29 Vancomycin
  • 13.30 Administering Vancomycin Antibiotics
  • 13.31 Vancomycin and Drug–Drug Interactions
  • 13.32 Vancomycins and Patient Education
  • 13.33 Aminoglycosides
  • 13.34 Administering Aminoglycosides
  • 13.35 Aminoglycosides and Drug–Drug Interactions
  • 13.36 Aminoglycosides and Patient Education
  • 13.37 Tetracyclines
  • 13.38 Administering Tetracyclines
  • 13.39 Tetraclyclines and Drug–Drug Interactions
  • 13.40 Tetracyclines and Patient Education
  • 13.41 Chloramphenicol (Chloromycetin)
  • 13.42 Chloramphenicol and Drug–Drug Interactions
  • 13.43 Chloramphenicol and Patient Education
  • 13.44 Fluoroquinolones
  • 13.45 Administering Fluoroquinolones
  • 13.46 Fluoroquinolones and Drug–Drug Interactions
  • 13.47 Fluoroquinolones and Patient Education
  • 13.48 Miscellaneous Antibiotics
  • 13.49 Sulfonamides
  • 13.50 Administering Sulfonamides
  • 13.51 Sulfonamides and Drug–Drug Interactions
  • 13.52 Sulfonamides and Patient Education
  • Chapter 14. Respiratory Diseases and Medication
  • 14.1 Respiration
  • 14.2 Compliance
  • 14.3 Controlling Respiration
  • 14.4 The Tracheobronchial Tube
  • 14.5 Respiratory Tract Disorders
  • 14.6 Acute Rhinitis (The Common Cold)
  • 14.7 Home Remedies for Acute Rhinitis
  • 14.8 Medications for Acute Rhinitis
  • 14.9 Sinusitis
  • 14.10 Acute Pharyngitis (Sore Throat)
  • 14.11 Acute Tonsillitis
  • 14.12 Acute Laryngitis
  • 14.13 Lower Respiratory Disorders
  • 14.14 Pneumonia
  • 14.15 Tuberculosis
  • 14.16 Chronic Bronchitis
  • 14.17 Bronchiectasis
  • 14.18 Emphysema
  • 14.19 Acute Asthma
  • 14.20 Medications to Treat Chronic Obstructive Pulmonary Disease
  • Chapter 15. The Neurologic System and Medication
  • 15.1 The Nervous System
  • 15.2 Neurologic Pathways
  • 15.3 Central Nervous System Stimulants
  • 15.4 Migraine Headaches
  • 15.5 Treatment for Migraine Headaches
  • 15.6 Central Nervous System Depressants
  • 15.7 Sedative-Hypnotics
  • 15.8 Barbiturates
  • 15.9 Anesthetic Agents
  • 15.10 Administering General Anesthetic Agents
  • 15.11 Four Stages of Anesthesia
  • 15.12 Topical Anesthetic Agents
  • 15.13 Local Anesthesia
  • 15.14 Spinal Anesthesia
  • 15.15 Autonomic Nervous System and Adrenergic Blockers
  • 15.16 The Fight or Flight Response
  • 15.17 Adrenergics and Adrenergic Blockers
  • 15.18 Alpha-Adrenergic Blockers
  • 15.19 Beta-Adrenergic Blockers
  • 15.20 Cholinergics
  • 15.21 Anticholinergics
  • 15.22 Antiparkinsonism-Anticholinergic Medication
  • 15.23 Skeletal Muscle Relaxants
  • 15.24 Parkinsonism Medication
  • 15.25 Myasthenia Gravis
  • 15.26 Multiple Sclerosis
  • 15.27 Alzheimer's Disease
  • 15.28 Muscle Spasms
  • 15.29 Epilepsy
  • 15.30 Antipsychotics
  • 15.31 Phenothiazines
  • 15.32 Anxiolytics
  • 15.33 Antidepressants
  • Chapter 16. Narcotic Agonists
  • 16.1 Pain
  • 16.2 The Gate Control Theory
  • 16.3 Defining Pain
  • 16.4 Assessing Pain
  • 16.5 Pain Management Treatment Plans
  • 16.6 Nonpharmacologic Management of Pain
  • 16.7 Pharmacologic Management of Pain
  • 16.8 Narcotic Analgesics
  • 16.9 Narcotic Agonist-Antagonists
  • 16.10 Narcotic Antagonists
  • Chapter 17. Immunologic Agents
  • 17.1 The Immune System
  • 17.2 Human Immunodeficiency Virus and the Immune System
  • 17.3 Human Immunodeficiency Virus Therapies
  • 17.4 Human Immunodeficiency Virus Medication
  • 17.5 Human Immunodeficiency Virus Therapy and Pregnancy
  • 17.6 Postexposure Prophylaxis
  • 17.7 Types of Immunity
  • 17.8 Vaccines
  • 17.9 Administering Vaccinations
  • 17.10 Patient Education
  • 17.11 Immunosuppressant Medication
  • Chapter 18. The Gastrointestinal System
  • 18.1 The Gastrointestinal System
  • 18.2 The Esophagus
  • 18.3 The Stomach
  • 18.4 The Intestines
  • 18.5 Vomiting and Nausea
  • 18.6 Causes of Vomiting
  • 18.7 Nonpharmacological Treatment of Vomiting
  • 18.8 Pharmacological Treatment of Vomiting
  • 18.9 Prescription Antiemetics
  • 18.10 Emetics
  • 18.11 Antidiarrhea Medications
  • 18.12 Constipation
  • 18.13 Peptic Ulcers
  • Chapter 19. Cardiac Circulatory Medications
  • 19.1 The Cardiovascular System
  • 19.2 The Heart
  • 19.3 Coronary Arteries
  • 19.4 Blood Pressure
  • 19.5 Circulation
  • 19.6 Blood
  • 19.7 Cardiac Medications
  • 19.8 Glycosides
  • 19.9 Antianginals
  • 19.10 Antidysrhythmics
  • 19.11 Heart Failure Medication
  • 19.12 Hypertension
  • 19.13 Blood Pressure and Kidneys
  • 19.14 Antihypertensives
  • 19.15 Combining Antihypertensive Drugs
  • 19.16 Angiotensin Antagonists, ACE Inhibitors, and Angiotensin II
  • 19.17 Diuretics
  • 19.18 Types of Diuretics
  • 19.19 Thiazide Diuretics
  • 19.20 Loop or High-Ceiling Diuretics
  • 19.21 Osmotic Diuretics
  • 19.22 Carbonic Anhydrase Inhibitors
  • 19.23 Potassium-Sparing Diuretics
  • 19.24 Circulatory Medication
  • 19.25 Anticoagulants and Antiplatelets
  • 19.26 Thrombolytics
  • 19.27 Antilipemics
  • 19.28 Peripheral Vascular Disease
  • Chapter 20. Skin Disorders
  • 20.1 The Skin
  • 20.2 Skin Disorders
  • 20.3 Acne Vulgaris
  • 20.4 Psoriasis
  • 20.5 Warts
  • 20.6 Dermatitis
  • 20.7 Alopecia
  • 20.8 Burns
  • 20.9 Abrasions and Lacerations
  • Chapter 21. Endocrine Medications
  • 21.1 The Endocrine System
  • 21.2 Hormones
  • 21.3 The Pituitary Gland: Growth Hormone
  • 21.4 The Pituitary Gland: Antidiuretic Hormone and Oxytocin
  • 21.5 The Adrenal Gland
  • 21.6 The Thyroid Gland
  • 21.7 Hypothyroidism
  • 21.8 Hyperthyroidism
  • 21.9 The Parathyroid Glands
  • 21.10 The Pancreas
  • 21.11 Insulin
  • 21.12 Oral Antidiabetics
  • 21.13 Medication That Increases Glucose
  • Chapter 22. Eye and Ear Disorders
  • 22.1 Eye Disorders
  • 22.2 Eye Medication
  • 22.3 Eye Medication: Patient Education
  • 22.4 Ear Disorders
  • 22.5 Ear Medication: Patient Education
  • Index